Outset Medical, Inc.
NASDAQ:OMMedical - Devices
Healthcare
$2.91 +18.16%
+$0.73 today
- Market cap
- $54.86M
- Beta
- 1.94
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$4.07
52W Low $3.00High $21.36
Volume 0.08M
Average 0.16M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$46.33M
FY 2025 · Annual
Investing Cash Flow
-$97.68M
FY 2025 · Annual
Financing Cash Flow
$55.50M
FY 2025 · Annual
-18.2% YoYCash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (131.94M) | (162.96M) | (172.8M) | (127.98M) | (81.65M) |
| Depreciation & Amortization | 5.16M | 5.17M | 5.81M | 5.73M | 4.34M |
| Deferred Income Tax | 3.08M | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 17.45M | 27.2M | 38.63M | 29.36M | 15.62M |
| Change in Working Capital | (25.6M) | (21.14M) | (773K) | (25.69M) | 2.2M |
| Accounts Receivables | (19.14M) | (2.51M) | (5.09M) | (5.01M) | 3.78M |
| Inventory | (22.04M) | (14.73M) | 1.65M | (10.86M) | 11.79M |
| Accounts Payables | (3.07M) | (1.28M) | 5.31M | (1.95M) | (3.29M) |
| Other Working Capital | 18.64M | (2.63M) | (2.64M) | (7.87M) | (10.08M) |
| Other Non-Cash Items | 1.59M | 6M | (2.25M) | 2.28M | 13.17M |
| Operating Cash Flow | (130.26M) | (145.73M) | (131.37M) | (116.3M) | (46.33M) |
| Capital Expenditures | (3.11M) | (8.33M) | (3.44M) | (912K) | (798K) |
| Acquisitions (Net) | 139.4M | 57.97M | 0 | 0 | 0 |
| Purchases of Investments | (178.43M) | (261.15M) | (172.28M) | (156.58M) | (221.97M) |
| Sales of Investments | 39.03M | 203.18M | 258.75M | 261.43M | 125.08M |
| Other Investing Activities | (139.4M) | (57.97M) | 0 | 0 | 0 |
| Investing Cash Flow | (142.51M) | (66.3M) | 83.03M | 103.94M | (97.68M) |
| Debt Repayment | 0 | 64.86M | 33.23M | 66.52M | (106.68M) |
| Common Stock Issued | 149.09M | 8.04M | 10.43M | 2.28M | 162.19M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 11.06M | 0 | 0 | (938K) | 0 |
| Financing Cash Flow | 160.15M | 72.9M | 43.65M | 67.87M | 55.5M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (112.62M) | (139.13M) | (4.7M) | 55.51M | (88.51M) |
| Free Cash Flow | (133.37M) | (154.05M) | (134.81M) | (117.22M) | (47.13M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$81.7M
+ D&A$4.3M
+ Stock-Based Comp$15.6M
+ Deferred Tax$0
+ Working Capital$2.2M
+ Other Non-Cash$13.2M
= Operating Cash Flow-$46.3M
- Capex-$798.0K
= Free Cash Flow-$47.1M
Analysis
FY2025 free cash flow is -$47.1M. FCF conversion is 57.7% of net income. Operating cash flow was -$46.3M, with capex of -$798.0K. The largest bridge item is Stock-Based Comp at $15.6M.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G/A | SC 13G/A filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| SC 13G/A | SC 13G/A filing | Oct 6, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 5, 2026 |
Does OM generate free cash flow?
Outset Medical, Inc. (OM) generated -$47.13M of free cash flow in fiscal 2025.
How much operating cash flow does OM produce?
Operating cash flow was -$46.33M, before capital expenditures of $798,000.00.
Continue the stock analysis
Jump to another research area for this company.